Losartan Potassium
Product Images NDC 50090-5406
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 50090-5406). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image002 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 02)
This is a medical research report that displays the results of patients treated with Atenolol and Losartan Potassium drugs. The report states the adjusted risk reduction percentage, which is 13%, with a p-value of 0.021. The horizontal axis shows different study months (from 6 to 66) while there's no clear information about the vertical axis.*
Image003 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 03)
Image004 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 04)
This is a tabular representation of the results of a study comparing the effectiveness of Losartan and Atenolol in reducing the incidence of Primary Composite Stroke among patients. The table shows the number of patients who experienced the outcome under consideration, the rate of the outcome, the hazard ratio, and 95% confidence interval for Losartan and Atenolol treatments. The patients are also categorized based on age, gender, race, history of CVD, diabetes, and other factors. The details of the study are not available.*
Image005 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 05)
Label Image (Lbl500905406)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.